Global Point Of Care Glucose Testing Market: Overview
Point-of-care glucose testing is used to monitor diabetic patients, and they are also referred to as near-patient testing. Also, it has emerged as an efficient tool that helps manage patients, particularly in outpatient settings. However, the point-of-care glucose system device and electronic healthcare records help share the test results quickly with the medical providers. It also aids in reducing turnaround time and facilitating rapid decision-making abilities. It helps reverse life-threatening diseases like diabetic ketoacidosis, hypoglycemic seizures, and many others. However, the point-of-care glucose testing device is widely used in ICU.
Report Scope:
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
Global Point Of Care Glucose Testing Market: Growth Factors
The global point of care glucose testing market is anticipated to expand with a considerable CAGR of 3.8% during the forecast period. One of the major reasons for the growth of the global point of care glucose testing market is the constantly growing geriatric population globally. Also, there is a significant spike in the number of diabetic patients across the globe, thereby expanding the scope of point-of-care glucose testing. According to the International Diabetes Federation, around 578 million people are likely to struggle with diabetes by 2030 and around 700 million by the end of 2045. Additionally, the capability of POC diagnostic tests to produce quick results will further facilitate improved patient care. However, the scarcity of skilled staff is one of the other key factors propelling the growth of the global point of care glucose testing market. People are getting more aware of the proper diabetes management process and its associated benefits, thereby stimulating the demand for point-of-care glucose testing globally. The ongoing technological advancements and innovations focus on bringing more convenient and advanced featured products to the market; as a result, it is likely to throw strong growth prospects in the forthcoming years. Simultaneously, manufacturers are boosting their research and development activities along with increasing investment in research and operation activities. However, the advent of the Covid-19 pandemic globally has positively impacted the growth of the global point of care glucose testing market as diabetes scaled up the risk of mortality from coronavirus infection. Therefore, the demand is likely to grow manifolds in the forthcoming years. However, the ongoing new product launches with improved capabilities are further strengthening the market growth exponentially.
Global Point Of Care Glucose Testing Market: Segmentation
The global point of care glucose testing market can be segmented into end-user, testing site, product, and region.
By end-user, the market can be segmented into home care settings, hospital & clinics, professional diagnostic centers, and others. The home care setting segment accounts for the largest share in the global point of care glucose testing market due to the growing demand for cost-effective home health care devices. The ongoing technological advancements in these glucose testing devices will further stimulate the growth of the segment.
By testing the site, the market can be segmented into alternate site testing and fingertip.
By product type, the market can be segmented into meters, lancets & lancing devices, and strips.
Global Point Of Care Glucose Testing Market: Regional analysis
North America accounts for the largest share in the global point of care glucose testing market due to the presence of leading market players in the region. However, the easy availability of glucose testing products is likely to further contribute to the growth of the regional market. Also, the higher healthcare expense by the government on diabetes management will also strengthen the regional market.
Asia Pacific is likely to grow significantly during the forecast period due to the growing disposable income of the people in the region. Also, the constantly growing geriatric population and growing awareness among people regarding the availability of home care testing kits will further propel the growth of the regional market.
Global Point Of Care Glucose Testing Market: Competitive Players
Some of the significant players in the global point of care glucose testing market include Johnson & Johnson, Quidel, PTS Diagnostic, PTS Diagnostic, Instrumentation Laboratories, Dickinson, Siemens Corporation, Becton, Nova Biomedical, Trividia Health, Ascensia Diabetes Care, Lifescan IP Holdings, LLC, Abbott, and Hoffmann-La-Roche Diabetes Care Ltd.
Global Point Of Care Glucose Testing Market: Regional Segment Analysis
What Reports Provides
Request the coronavirus impact analysis across industries and markets
The global point of care glucose testing market is anticipated to expand with a considerable CAGR of 3.8% during the forecast period. One of the major reasons for the growth of the global point of care glucose testing market is the constantly growing geriatric population globally. Also, there is a significant spike in the number of diabetic patients across the globe, thereby expanding the scope of point-of-care glucose testing.
Some of the significant players in the global point of care glucose testing market include Johnson & Johnson, Quidel, PTS Diagnostic, PTS Diagnostic, Instrumentation Laboratories, Dickinson, Siemens Corporation, Becton, Nova Biomedical, Trividia Health, Ascensia Diabetes Care, Lifescan IP Holdings, LLC, Abbott, and Hoffmann-La-Roche Diabetes Care Ltd.
North America accounts for the largest share in the global point of care glucose testing market due to the presence of leading market players in the region. However, the easy availability of glucose testing products is likely to further contribute to the growth of the regional market.
Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No 020-46277770
US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed